Given the emerging role of Cullin-RING ubiquitin ligases in ovarian cancer chemoresistance, targeting the activity of Cullin-RING complexes may be an efficacious anticancer strategy for targeted ovarian cancer therapy. Here, CACUL1 is linked to ovarian carcinoma.